Anzeige
Mehr »
Login
Sonntag, 11.04.2021 Börsentäglich über 12.000 News von 660 internationalen Medien
Kurseskalation am Montag? Diese Gamechanger-News macht es möglich!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2DFYA ISIN: BMG637AM1024 Ticker-Symbol: 71M 
Tradegate
09.04.21
20:33 Uhr
15,150 Euro
-0,280
-1,81 %
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
MYOVANT SCIENCES LTD Chart 1 Jahr
5-Tage-Chart
MYOVANT SCIENCES LTD 5-Tage-Chart
RealtimeGeldBriefZeit
14,94015,55009.04.

Aktuelle News zur MYOVANT SCIENCES Aktie

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MYOVANT SCIENCES Aktie jetzt für 0€ handeln
DiMyovant Sciences Ltd. - S-8, Securities to be offered to employees in employee benefit plans5
MoMyovant Sciences names industry veteran as commercial chief4
MoMyovant Sciences, Inc.: Myovant Sciences Appoints Lauren Merendino as Chief Commercial Officer1
25.03.Myovant's (MYOV) Data on Relugolix for Uterine Fibroids Positive7
24.03.Myovant adds relugolix data in uterine fibroids ahead of June PDUFA; Mubadala teams up with UK for $1B+ fund4
24.03.Myovant/Pfizer's Relugolix Combo Therapy Shows Sustained Clinical Benefit In Uterine Fibroids4
24.03.Myovant & Pfizer: Long-term Study Supports Potential Benefit Of Relugolix Combination Therapy259NEW YORK CITY (dpa-AFX) - Myovant Sciences (MYOV) and Pfizer Inc. (PFE) reported positive data from the phase 3 LIBERTY randomized withdrawal study of relugolix combination therapy in women...
► Artikel lesen
24.03.Pfizer, Myovant Sciences' relugolix combo shows positive action in uterine fibroids4
24.03.Myovant Sciences, Inc.: Myovant Sciences and Pfizer Announce Positive Data from Phase 3 LIBERTY Randomized Withdrawal Study of Once-Daily Relugolix Combination ...8
23.03.Myovant Sciences, Inc.: Myovant Sciences Announces Recipients of "Forward for Health Equity" Grants to Improve Healthcare Access in Prostate Cancer and ...2
22.02.Myovant Sciences, Inc.: Myovant Sciences to Present at Upcoming Investor Conferences5
18.02.Myovant, Pfizer's relugolix combo shows durable efficacy in uterine fibroids16
17.02.Myovant Sciences, Inc.: Myovant Sciences and Pfizer Announce Publication in the New England Journal of Medicine of Phase 3 LIBERTY Studies of Once-Daily ...12
17.02.Myovant Sciences, Inc.: Myovant Sciences Announces New Employment Inducement Grants Under NYSE Rule 303A.083
16.02.Myovant Sciences, Inc.: HealthyWomen and Myovant Sciences Launch "Voices of Periods" to Fight Menstrual Stigma5
11.02.Myovant Sciences Ltd. (MYOV) CEO Dave Marek on Q3 2020 Results - Earnings Call Transcript11
11.02.Myovant Sciences: Q3 Earnings Insights13
11.02.Myovant Sciences Ltd. - 10-Q, Quaterly Report3
11.02.Myovant Sciences EPS beats by $0.03, misses on revenue2
11.02.Myovant Sciences Ltd. - 8-K, Current Report2
Seite:  Weiter >>
74 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,3